Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
E1WL34 | B3 | BRL | Delayed | |
EW | NYSE | USD | Real-time | |
EW | Mexico | MXN | Delayed | |
1EW | Milan | EUR | Real-time | |
EW | Frankfurt | EUR | Delayed | |
EW | TradeGate | EUR | Delayed | |
EW | Vienna | EUR | Real-time |
Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient’s heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Name | Age | Since | Title |
---|---|---|---|
Bernard J. Zovighian | 55 | 2015 | CEO & Director |
Leslie Stone Heisz | 64 | 2016 | Independent Director |
Nicholas J. Valeriani | 67 | 2014 | Independent Chairman |
Leslie C. Davis | 65 | 2024 | Independent Director |
Kieran T. Gallahue | 61 | 2015 | Independent Director |
Ramona Sequeira | 59 | 2020 | Independent Director |
Paul Arthur LaViolette | 66 | 2020 | Independent Director |
Steven R. Loranger | 72 | 2016 | Independent Director |
David Todd Feinberg | 62 | 2024 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review